Synergy Disc vs. ACDF Surgery for Degenerative Disc Disease
Trial Summary
What is the purpose of this trial?
A multicenter, prospective, non-randomized, historically controlled study. To demonstrate the Synergy Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) to treat cervical degenerative disc disease (DDD) in subjects who are symptomatic at two levels from C3 to C7 are and are unresponsive to conservative management. Patients will be evaluated preoperatively, at the time of surgery, and at 6 weeks, and 3, 6, 12, and 24 months after surgery. Follow-up will continue annually until the last patient reaches 24-month follow-up. The primary analysis will occur at 24 months.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, you cannot participate if you have taken drugs that interfere with bone metabolism, like steroids or methotrexate, within two weeks before surgery, or if you need medications that affect implant stability after surgery.
What data supports the effectiveness of the treatment Synergy Disc for Degenerative Disc Disease?
Research comparing cervical disc arthroplasty (a type of surgery that preserves motion) with anterior cervical discectomy and fusion (ACDF) shows that disc arthroplasty can be effective for treating degenerative disc disease, suggesting that similar treatments like the Synergy Disc may also be beneficial.12345
Is the Synergy Disc generally safe for humans?
The available research primarily compares the safety of anterior cervical discectomy and fusion (ACDF) and cervical total disc replacement (cTDR), but does not specifically address the safety of the Synergy Disc. However, these studies suggest that both ACDF and cTDR have known complications, and safety varies based on factors like patient age and surgical setting.678910
How is the Synergy Disc treatment different from ACDF surgery for degenerative disc disease?
The Synergy Disc treatment is unique because it aims to preserve motion in the spine, unlike ACDF surgery, which fuses the vertebrae and can lead to loss of mobility and issues in adjacent segments. This motion-preserving approach may help reduce complications associated with traditional fusion surgeries.13111213
Research Team
Jane M Jacob, PhD
Principal Investigator
Synergy Spine Solutions
Eligibility Criteria
This trial is for adults over 18 with neck pain and cervical degenerative disc disease at two adjacent levels from C3 to C7, who haven't improved with non-surgical treatments. They must have a specific level of disability and pain, documented nerve compression, no severe facet joint issues or certain metabolic disorders, no recent investigational therapy or spinal surgeries (with some exceptions), not be pregnant or planning pregnancy during the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Evaluation
Patients are evaluated preoperatively to assess baseline conditions and eligibility for surgery
Surgery
Participants undergo surgery for the insertion of the Synergy Disc or conventional ACDF
Post-operative Follow-up
Participants are monitored at 6 weeks, and 3, 6, 12, and 24 months after surgery for safety and effectiveness
Annual Follow-up
Follow-up continues annually until the last patient reaches 24-month follow-up
Treatment Details
Interventions
- Synergy Disc
Find a Clinic Near You
Who Is Running the Clinical Trial?
Synergy Spine Solutions
Lead Sponsor
MCRA
Industry Sponsor